A paper coronavirus test could effectively replace more expensive, less accurate antigen tests in India

India has the world's second highest coronavirus case count and appears to be on pace to overtake the United States in the next few weeks. To counter the rising number of infections, the country has scaled up testing. It hasn't been an easy process, but now 1 million samples are tested daily across more than 1,200 labs, and a newly-developed paper-based test that uses CRISPR gene-editing tools to detect the virus could become the third type of test — after PCR and antigen — to bolster the national diagnostic effort, BBC News reports.
The new test, called Feluda after a famous fictional Indian detective, employs a nasal swab and can return results in less than hour, making it faster than PCR tests. Its 96 percent sensitivity and 98 percent specificity rate means it will likely be more accurate than the rapid antigen tests. It would also reportedly be more affordable than both. In short, there's hope it could be the best of the both worlds. "The new test has the reliability of the PCR test, is quicker and can be done in smaller laboratories which don't have sophisticated machines," said Dr. Anurag Agarwal, the director of the Delhi-based CSIR-Institute of Genomics and Integrative Biology, where Feluda was developed.
Dr. Stephen Kissler, a research fellow at Harvard Medical School, told BBC that if Feluda's "efficacy is demonstrated, it can have benefits that ripple around the world." The next step for the development team is to build a prototype of a similar test that can be done from home. Read more at BBC.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published